2023-06-28 09:55:02
German drugmaker Bayer said on Wednesday that initial human tests showed that an experimental stem cell treatment for Parkinson’s disease was well tolerated by patients, adding that the transplanted cells remained alive in their brains.
According to “Reuters”, the company stated that the positive results over a year of the first stage of treatment, which was carried out by Bluerock Therapeutics, encouraged it to develop a treatment test on humans and move it to the second stage out of three.
A few days ago, a study published in the Journal of the American Chemical Society reported that scientists had prepared an artificial intelligence program that could detect early signs of Parkinson’s disease years before the onset of symptoms in the body.
The program is called “CRANK-MS” and can be run on a laptop computer, and it detects tremors and slow movements in the body and analyzes what is happening in the neural network, which helps in predicting the disease.
The World Health Organization defines Parkinson’s disease as a degenerative brain condition associated with motor symptoms (slow movement, tremor, stiffness and imbalance) as well as other complications, including cognitive impairment, mental health disorders, sleep disorders, pain and sensory disturbances.
Global estimates in 2019 showed that more than 8.5 million people suffer from Parkinson’s disease.
According to the Mayo Clinic website, there is no specific test to diagnose Parkinson’s disease, but a doctor who specializes in nervous system conditions (neurologist) diagnoses Parkinson’s disease based on the medical history of the case, a review of the disease’s indicators and symptoms that appeared, and the results of the neurological and physical examination.
According to research published by The Lancet Neurology on Parkinson’s disease in the countries of the Middle East and North Africa, the habit of marriage between relatives that spreads in the countries of the region is one of the factors that mainly leads to the spread of Parkinson’s disease.
The research indicated that some studies conducted in the countries of the region pointed to the prevalence of Parkinson’s disease during the past 25 years.
According to the study, a large percentage of workers in the agricultural sector who live in rural areas in many countries of the Middle East and North Africa region are exposed to hazards associated with rural life, such as pesticides.
The study draws attention, for example, to the hypothesis that the spread of Parkinson’s disease is highly linked in Assiut and Qena in Egypt to industrial toxic substances that are discharged from factories into the Nile River.
High levels of manganese were found in the water in these areas, and organochlorine pesticides were reported in samples of cow’s milk in Qena.
#Preliminary #results. #experimental #treatment #promise #Parkinsons #patients